// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
With significant innovations in pharmaceuticals, including biologic drugs
For people living in rural areas of the U.S., access to healthcare providers can be a serious cha
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis